InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-20.6%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Heinen Mark, Executive. Director active across 2 companies, notably Better Therapeutics, Inc.. Aggregated, 12 filings have been published. Split: 6 buys · 0 sell. Total volume traded: €12k. Activity tracked since 13 December 2021. The latest transaction was disclosed on 27 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Heinen Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
10,000 shares@ US$0.2626.5% of flowCommon StockSEC:0001628280-26-022229:0
45,000 shares0Common StockSEC:0001628280-25-024366:0
139,463 shares0Common StockSEC:0001628280-24-027731:0
8,500 shares@ US$0.80100.0% of flowCommon StockSEC:0001628280-24-027587:0
Canonical exit: 4 Sept 2024 (T+90)
54,000 shares0Common StockSEC:0000950170-23-013898:0
15,723 shares@ €1.20221.1% of flowCommon StockSEC:0000899243-22-037417:0
23,868 shares@ €1.915251.1% of flowCommon StockSEC:0000899243-22-031045:0
Canonical exit: 11 Dec 2022 (T+90)
2,280.605 shares@ US$1.753969.75% mcap15.3% of flowCommon StockSEC:0000899243-22-024391:0
Canonical exit: 22 Sept 2022 (T+90)
5,000 shares@ €1.46929.5% of flowCommon StockSEC:0000899243-22-021998:0
Canonical exit: 8 Sept 2022 (T+90)
5,000 shares@ €1.788235.9% of flowCommon StockSEC:0000899243-22-013344:0
Canonical exit: 29 Jun 2022 (T+90)
500 shares@ US$5.4544.19% mcap9.7% of flowCommon StockSEC:0000899243-21-048374:0
Canonical exit: 13 Mar 2022 (T+90)
6,667 sharesCommon StockSEC:0000899243-21-042247:0
12 of 12 declarations
About Heinen Mark
Heinen Mark is an executive at Better Therapeutics, Inc., a health technology company. He contributes to the strategic and operational direction of the company, aiming to develop innovative solutions.
